Dr. Kyle William Binder, MD, PhD

Dr. Binder practices at Health First Medical Group in Rockledge, Florida.

Dr. Binder's NPI, 1841635422, was assigned on May 8, 2013. Dr. Binder graduated from Wake Forest School of Medicine in 2013. Dr. Binder's Oregon license number on file is MD215257.

Dr. Binder's primary practice is Health First Medical Group, at 3300 S Fiske Blvd, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 434-5055.

Dr. Binder's primary practice is Health First Medical Group in Rockledge, Florida. Dr. Binder is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Binder to 4 more hospitals, 27 medical groups and 18 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Binder practices, 23 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Binder's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Binder is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Binder's licenses on file in 15 states: Oregon, California, Montana, New Jersey, Nevada, Ohio, South Carolina, Arizona, Florida, Iowa, Idaho, Kentucky, Maryland, Michigan and Missouri.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, encephalopathy, head injury, hereditary polyneuropathy, lower back pain and migraine and chronic headache among the conditions Dr. Binder treats.

CMS data shows 239 Medicare services from Dr. Binder across 6 procedure codes in 2024, for 261 Medicare patients. Medicare paid $21,123 for them.

CMS counts 261 Medicare patients who saw Dr. Binder in 2024. The largest group is 75 to 84, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Binder's median patient age at 67, with 58% women.

In 2024, Dr. Binder wrote 53 Medicare Part D claims for 21 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $272 in total drug cost. In 2023, CMS named 270 claims across 13 drugs.

Dr. Binder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Binder as offering telehealth.

Dmand AI links 6 papers to Dr. Binder, published from 2012 to 2023. The most frequent topics are Biocompatible Materials and Tissue Scaffolds. Dr. Binder's most frequent co-authors are Jenna Ruth Ember Bergerson, MD, Ivan Chinn, MD and Les R. Folio, DO.

CMS Open Payments shows 340 general payments to Dr. Binder from 48 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,165.

Dr. Binder graduated from Wake Forest School of Medicine in 2013.

Dr. Binder is in network with 25 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.